DiscoverThe Talent Lab
The Talent Lab
Claim Ownership

The Talent Lab

Author: Brad McMillan & Marina Hart

Subscribed: 0Played: 0
Share

Description

Welcome to The Talent Lab — a behind-the-scenes look at the people, trends, challenges, and occasional chaos shaping the life sciences talent market.
Hosted by Brad McMillan and Marina Hart of RPM ReSearch Solutions, the podcast explores biotech, pharma, CROs, animal health, and beyond through honest conversations about hiring, leadership, innovation, women in bio, career growth, and workplace culture.
Practical insights, real conversations, and the humans behind the science.
10 Episodes
Reverse
“Hiring is not merely an HR activity. It is an Operating System that determines whether the business can execute its plans”In Episode 10 of The Talent Lab, Brad McMillan and Marina Hart examine a common hiring mistake: treating a process problem as a staffing problem. More sourcing, more outreach, and more recruiting hours may not help when qualified candidates keep running into the same delays.They explain the difference between executive search, recruitment process outsourcing (RPO), and RPM ReSearch’s process consulting—and how to determine which type of support your organization actually needs.In this episode, we cover:The hidden cost of vacant roles: How an unfilled position can affect team productivity, delay decisions, and limit revenue.Where hiring gets stuck: Unclear role expectations, repetitive interviews, slow feedback, and offer approval delays.RPM’s diagnostic framework: A review of 86 critical control points across eight hiring phases, from role definition through post-start retention.When to look beyond sourcing: Warning signs such as candidate withdrawals, repeated offer declines, and rising recruiting spend without more hires.Brad and Marina also explain four ways RPM supports organizations: a hiring system health assessment, a hiring process diagnostic, a process optimization sprint, and ongoing guidance from a fractional talent advisor.This isn’t about blaming recruiters, replacing your internal team, or buying another software tool. It’s about identifying what is getting in your team’s way and building a process that helps them succeed.Fix the system, then execute.Visit RPM ReSearch’s website to complete the hiring bottleneck self-assessment and identify where your process needs attention before your next search.https://rpmresearch.solutions/
What does it actually take to build a drug program that survives?In Episode 10, Brad and Marina sit down with Dr. Kevin Bacon — pharmacologist, startup founder, and 35-year veteran of drug discovery and clinical development. Kevin has built programs in respiratory disease and vaccines, led cross-functional teams across the US, Europe, and Japan, and helped companies find their path from early-stage asset to exit.In this conversation, Kevin unpacks what he calls the science executive mindset: why the science behind the molecule is the make-or-break variable that investors and boards often ignore until it's too late. He also talks about the financing pressures reshaping biotech right now, why so many job descriptions are setting companies up to fail, and where AI genuinely helps — and where humans still have to be in the room.In this episode:→ Why Kevin calls himself a science executive — not a biotech executive→ The real reason biotech programs fall apart in clinical development→ The 2023–2024 bust: what actually caused it→ AI in drug discovery: where it adds value and where it doesn't→ Why biotech job descriptions have become unrealistic — and what to do instead→ What global leadership taught Kevin about people being the cornerstone of this industry
In Episode 08 of The Talent Lab, Marina Hart sits down with Dr. Laura Berenger for a conversation that goes far beyond job titles.Laura works at the intersection of toxicology, biocompatibility, regulatory science, and patient safety. Her work helps answer a high-stakes question before a medical device ever reaches the market:Is it truly safe for the human body? But this episode is about more than science.It is about what it means to be a woman in biotech while making difficult decisions, delivering uncomfortable truths, and staying grounded in your convictions in rooms that do not always make space for your voice. Marina and Laura talk about:what biocompatibility really means in plain Englishwhy safety decisions need to start early in device developmentwhere animal testing, alternative methods, and AI fit into the future of safety sciencewhy mentorship matters for women in technical fieldsthe pressure women still face to be likable, measured, and easy to hearand why “having it all” is often one of the most damaging myths women are sold One of the biggest takeaways from this episode:Do not build your career around being liked. Build it around conviction, ethics, and doing the work that matters.This is a smart, honest conversation about science, leadership, motherhood, mentorship, and the reality of being a woman in bio today.
Most people do not have a résumé problem because they need a total rewrite.They have a résumé problem because the document they are using is not doing its job.It is too long.Too vague.Too focused on responsibilities instead of relevance.And too often written to explain the past instead of earn the next conversation. In this episode of The Talent Lab, Marina Hart and Brad McMillan break down a practical Résumé Rehab approach for professionals who need to improve their résumé quickly without turning it into a massive project.They cover what to cut, what to tighten, how to make your experience easier to scan, how to handle location and LinkedIn, and why showing impact matters more than listing duties. They also explain the difference between Brad’s long-term Keystone Résumé strategy and the faster, more tactical fixes job seekers can make right now. This episode is for anyone in the market who wants a clearer, sharper résumé that gives hiring teams a reason to keep reading.Because your résumé does not need to tell your whole story.It needs to make the right person want to talk to you.https://rpmresearch.solutions/featured-jobs/
In this episode of The Talent Lab, Marina Hart sits down with Angeliki Kotsianti for a powerful conversation on women in biotech, leadership, oncology innovation, and the future of career growth in life sciences.Together, they explore what it really takes to move science into impact, why value matters more than elegant ideas alone, and how women can stop waiting to be recognized and start becoming impossible to ignore. Angeliki shares hard-earned insight on leadership, visibility, negotiation, portfolio careers, fractional work, and building influence in rooms where decisions shape industries.This is a conversation about science, strategy, ambition, and creating your own seat at the table.What you’ll hear in this episode:Why translational science starts with patient impactWhat leadership looks like before recognition arrivesWhy visibility is a strategy, not vanityHow women in biotech can rethink negotiation and influenceWhy portfolio careers and fractional leadership may be the futureA must-listen for women in science, biotech leaders, founders, and anyone building a career with purpose. https://www.linkedin.com/in/angeliki-kotsianti/https://rpmresearch.solutions/featured-jobs/
loading
Comments